Molecular docking
Explore 3 research publications tagged with this keyword
Publications Tagged with "Molecular docking"
3 publications found
2026
2 publicationsPsoralen Analogues with Reduced Phototoxicity: Structural Strategies, Biological Mechanisms, and Computational Opportunities
Psoralen is an endogenous compound with a linear furocoumarin structure, having a tricyclic structure in which coumarin and furan ring are present. The psoralen and its analogues are highly researched compounds in medicinal chemistry due to their various biological activities and use in photochemotherapy. It is known for its therapeutic activity in association with DNA interaction and photochemical reactions after exposure to ultraviolet A (UVA) light. Psoralen has the capability of forming a covalent adduct with the pyrimidine bases; however, further photochemical reactions may lead to formation of DNA interstrand cross-linking, affecting the replication and transcription of DNA. These reactions are responsible for the therapeutic action of psoralen but may also lead to phototoxicity and DNA damage. Modification in psoralen structure may be helpful in finding analogues with biological activity without phototoxicity. Changes in specific sites, such as C5 and C8, along with the modification of functional groups and heterocycles, have been proposed as methods for studying the properties of molecules. Molecular docking, physicochemical analysis, and ADMET prediction may help in screening potential compounds. Nevertheless, it is impossible to prove by computational models that the compounds are less phototoxic or capable of action without UVA.
β-Lapachone and Its Derivatives: Synthetic Strategies, Structure–Activity Relationships, Pharmacological Activities, and Computational Approaches
β-Lapachone (β-Lap) is a naturally occurring ortho-naphthoquinone found in the heartwood of Handroanthus impetiginosus and other lapacho trees. The compound has been studied extensively due to its promising anticancer potential in cancer cells with high expression of NAD(P)H:quinone oxidoreductase 1 (NQO1). Reduction of β-Lap by NQO1 leads to the formation of a highly unstable hydroquinone intermediate which undergoes oxidation in a futile redox cycle, generating excessive amounts of ROS. The resultant oxidative stress can lead to DNA damage, hyperactivation of PARP1, reduction of NAD+ and ATP levels and cell death in cancer cells. Although β-Lap exhibits promising pharmacological effects, its poor solubility in water, problems with formulation and pharmacokinetics, possible toxic effects associated with dosing and limited therapeutic window limit the clinical applications of the parent compound. Therefore, various modifications of β-Lap structure were performed using the arylamino, alkoxy, thiosemicarbazone, oxime and prodrug strategies. Computer-assisted drug design approaches such as molecular docking, electronic-structure calculation and ADMET predictions serve as additional methods of selection of promising β-Lap derivatives before synthesis and testing. The present review gives a summary of the chemistry, physicochemical properties, SAR, pharmacology, synthetic and computational approaches to β-Lap and its derivatives [1-3,6]. The review was performed on published scientific papers based on β-lapachone, structural derivatives of β-lapachone, anticancer potential, molecular docking, and computational ADMET study. β-Lapachone was taken into account as the main parent compound, and structural derivatives, including arylamino, alkoxy, oxime, thiosemicarbazone, and other groups, were discussed. The computational methods, including molecular docking, were considered for the assessment of the interaction between the ligands and their targets (proteins) involved in the process of cancer development such as NQO1 and Topoisomerase IIα. Binding interactions, docking score, hydrogen bonding, hydrophobic, and π-π interactions were studied according to the reported studies. Besides, the pharmacokinetic and toxicity properties were also evaluated through ADMET prediction to obtain better anticancer agents [1,4,6,7]
2016
1 publicationMolecular Docking, Synthesis and Evaluation of Antianxiety and Anticonvulsant potential of some Novel 3-(substituted benzylidene)-5-phenyl-7-nitro-1, 3-dihydro-1H, 3H-1,4-Benzodiazepine-2-one
The given title proposed with the aim to synthesize some novel benzylidene substituted benzodiazepine analogue to evaluate GABAA receptor inhibitory activity. Molecular docking simulation studies were also performed on life molecular suite software. All compounds found to possess good dock score, but varied in formation of intermolecular complexes at the receptor site. Bonding interactions like hydrogen bonds, hydrophilic bonds and pi-interactions of the ligand library with receptor binding site were considered as parameter for synthesis of selected and potent molecules. Diazepam to be selected as the reference compound and included in ligand library to ran simultaneously. Diazepam found to develop two hydrogen bonds with TYR 106A amino acid residue whereas π-π stacking interaction with TYR 106A and PHE 3A protein moiety. It is capable to form hydrophobic interactions with PHE 104A, PHE 3A, VAL 4A, ILE 32A, TYR 6A, TYR 5A, LYS 6A, and ARG 14A. Most of the proposed compounds interacted in similar manner as diazepam. Dock score of diazepam and tested compounds were also comparable. All the synthesized molecules were characterized by IR, 1H-NMR and Mass spectrometric data. Elevated plus maze test and Maximal electroshock methods were selected to evaluate antianxiety and anticonvulsant activity respectively. Substitution of methoxy, ethoxy and dimethyl amino groups on benzylidene benzene found to have much therapeutic value but halogen and nitro substitution were not active even unable to show interaction forces with target receptor. Isopropyl group also found to possess potential effect on CNS.
